Males and females aged 18-40 years of age at the time of vaccination in good health as determined by medical history, physical exam, laboratory assessments and the clinical judgment of the Principal Investigator 
Able to provide informed consent indicating that they understand the purpose of this study and are willing to adhere to the procedures described in this protocol 
If the subject is a female of childbearing potential, she must use adequate contraceptive precautions (e.g., intrauterine contraceptive device, oral contraceptives or other equivalent hormonal contraception) for 2 months prior to vaccination and continue to use such precautions for a minimum of three months after vaccination. She must also have a negative urine pregnancy test within 24 hours prior to receiving study vaccine. Women at least one year post-menopausal or surgically sterile will not be considered of childbearing potential. 
Willing to receive the unlicensed vaccine given as an IM injection 
Willing to provide multiple blood specimens collected by venipuncture 

NCT02015494_inc_T1
Person
Males
NCT02015494_inc_T2
Person
females
NCT02015494_inc_T3
Person
aged
NCT02015494_inc_T4
Value
18-40 years
NCT02015494_inc_T5
Person
age
NCT02015494_inc_T6
Temporal
at the time of vaccination
NCT02015494_inc_T7
Reference_point
time of vaccination
NCT02015494_inc_T8
Condition
good health
NCT02015494_inc_T10
Observation
medical history
NCT02015494_inc_T11
Procedure
physical exam
NCT02015494_inc_T12
Procedure
laboratory assessments
NCT02015494_inc_T14
Scope
medical history, physical exam, laboratory assessments and the clinical judgment of the Principal Investigator
NCT02015494_inc_T18
Drug
vaccine
NCT02015494_inc_T19
Procedure
IM injection